Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Segments
  2. Solutions
  3. Insights
  4. Events
  5. About
  6. Contact Us
MAIN/search
MAIN/Segments
Segments/
Segments
  • Pharmaceutical
  • Consumer Health
  • MedTech
  • Public Health & Government
  • Payer & Provider
Pharmaceutical (Global page)

Bringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.

Learn More
Consumer Health

Connecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.

LEARN MORE
MedTech

Empowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.

Learn more
Public Health & Government

Working across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.

LEARN MORE
Payer & Provider

Delivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.

learn more
Healthcare Provider Solutions
MAIN/Solutions
Solutions/
Solutions
  • Research & Development
  • Real World Evidence
  • Information Insights
  • Market Research
  • Strategy Consulting
  • Contract Sales & Medical Solutions
  • Patient Solutions
  • AI, Digital & Technology Solutions
Research & Development (Global page)

Clinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.

Learn More
Real World Evidence

Harness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.

LEARN MORE
Information Insights

Pharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.

LEARN MORE
Market Research

Primary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.

LEARN MORE
Strategy Consulting (Global page)

Trusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.

LEARN MORE
Related Solutions
Contract Sales & Medical Solutions (Global page)

Optimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.

LEARN MORE
Patient Solutions (Global page)

A single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.

LEARN MORE
AI, Digital & Technology Solutions

Connected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.

LEARN MORE
MAIN/Insights
Insights/
Our Latest Whitepapers

Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific. 

Learn More
Blogs, Case Studies & Podcasts

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

Discover Insights

IQVIA APAC Insight

"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.

Read The Latest Issue
MAIN/Events
Events/
Upcoming Events & Webinars

View our upcoming events and webinars.

Explore The Latest
On-Demand Webinars

Visit our library of on-demand webinars.

Discover Insights

Featured Event

"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers

Learn More
MAIN/About
About/
Newsroom

Read the latest updates and press releases.

Learn More
Career Opportunities

Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

Search Jobs

APAC FOOTPRINT

"Explore our Asia Pacific locations.

Learn more
MAIN/Contact Us
Contact Us/
Blog
The Rise of Digital Therapeutics (DTx)
Heidi Lim, Associate Principal, IQVIA MedTech, Asia Pacific
Jul 06, 2020

Digital therapeutics (DTx) is a fast emerging class of therapies that utilizes software to treat disease, both as a standalone or for treatment optimization. DTx has a wide range of potential of applications from improving patient medication adherence to supporting healthcare professionals (HCPs) in managing their patients and businesses digitally. Moreover, by using artificial intelligence (AI) to interpret physiological data, DTx could be used to predict and manage a patient’s future health, rather than as a reaction to symptoms.

Across the healthcare ecosystem, stakeholders are increasing their DTx focus:

  1. Life Science companies are developing DTx that improve overall clinical outcomes
  2. Payers and providers can use DTx to treat increasing patient numbers at low cost
  3. In light of COVID-19, regulators are keen to encourage digital innovation to support treatment outside of healthcare facilitates.

DTx can bring personalized care to everyone, upstream as Life Science companies use real-world data to predict outcomes or downstream as patients receive care in the moment rather than waiting for a doctor’s appointment.

Allow continuous real-world data collection

DTx, whether preventative or management, by its nature tracks data and is therefore a ready repository of real-world data that can be used to communicate safety, cost-effectiveness and advocacy for market access. In addition, it’s ready to be connected to other data sources such as chat bots, decision support systems, and connected biosensors – creating a full map of the patient management. In the advent of Machine Learning algorithms, it can be used to look for text and image data, and better inform real-world use.

Deliver continuum of care outside of healthcare facilities

A triage of technology can allow HCPs to monitor patients in real time beyond healthcare facility settings and also support patients to take control of their health. Linking DTx to biosensors, smart watches, user-friendly apps can allow it to be an extension arm of healthcare providers. For example, in the US, DTx was used to treat Schizophrenia patients during the COVID-19 pandemic to reduce potential COVID-19 exposure at healthcare facilities.

In other uses, DTx can identify chronic disease patients at-risk of developing complications and triggering intervention before these exacerbate. A key benefit to the patient but also to payers who can save costs from early diagnosis and treatment, before incurring higher costs down the road. Propeller Health’s asthma platform demonstrated a 79% reduction in rescue inhaler use1 and a 57% reduction in asthma-related emergency department visits and hospitalizations2.

Recipe for success

DTx success strongly relies on seamless integration into current healthcare infrastructure and individual lifestyle. DTx strategy should consider how it can create value-add opportunities for the company, any gaps in internal DTx development capabilities but most importantly, how it can complement product portfolios to deliver holistic patient care.

DTx continues the human health journey with patient centricity at its core.

Authors:
Heidi Lim, Senior Consultant, IQVIA MedTech, Asia Pacific
Ruthie Burr, Consultant, Strategic Marketing and Business Development, Asia Pacific

For more information, please feel free to contact us



References
  1. Merchant, et al. J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):455-63
  2. Merchant et al., 2018, WAOJ. “Impact of a Digital Health Intervention on Asthma Resource Utilization”
Contact Us